Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
06/2010
06/24/2010CA2745297A1 Pyrimidin-2-ylamino derivatives and their use to treat inflammation
06/23/2010EP2199291A1 Process for preparation of pimobendan hydrochloride
06/23/2010EP2199282A1 Amide compound
06/23/2010EP2198867A1 Pyrimidine-based compounds useful as GSK-3 inhibitors
06/23/2010EP2197875A1 Diacylglycerol acyltransferase inhibitors
06/23/2010EP2197874A1 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use
06/23/2010EP2197872A1 Phenylisoquinoline and phenylquinazoline derivatives for the treatment of bone diseases
06/23/2010EP2197858A2 1,3,5-triazine-2,4,6-triamine compound or pharmaceutical acceptable salt thereof, and pharmaceutical composition comprising the same
06/23/2010EP2197857A2 Insecticidal (1,3,5)-triazinyl phenyl hydrazones
06/23/2010EP2197852A1 Spiro-condensed imidazolone derivatives inhibiting the glycine transporter
06/23/2010EP2197551A1 Soluble guanylate cyclase activators
06/23/2010EP2049477B1 Modulators of chemokine receptor activity, crystalline forms and process
06/23/2010EP1928857B1 Method for preparing (3-chloro-4-fluorophenyl)-(4-fluoro-4-{[(5methyl-pyrimidin-2-ylmethyl)-amino]-methyl}-piperidin-1-yl)-methanone and novel intermediate pyrimidine derivatives
06/23/2010EP1699782B1 Maleate salts of a quinazoline derivative useful as an antiangiogenic agent
06/23/2010CN1935793B Process for producing substituted aniline compound
06/23/2010CN1906173B Protein modifier production inhibitor
06/23/2010CN1688194B 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
06/23/2010CN101754966A Hepatitis c virus inhibitors
06/23/2010CN101754957A Novel heterocyclyl compounds and their use as chemokine antagonists
06/23/2010CN101754762A Formulations containing pyrid azine compound field of invention
06/23/2010CN101747324A Sulfonamide derivatives
06/23/2010CN101747322A Pyridazinone derivatives with 1,2,4-triazole schiff base, preparation method and application thereof
06/23/2010CN101747321A Indole-3-benzylamine derivative, preparation method and application
06/23/2010CN101747282A Phenyl pyrimidone compounds, pharmaceutical compositions and preparation methods and uses thereof
06/23/2010CN101747253A Trisubstituted chiral lactam derivative and preparation method and application thereof
06/23/2010CN101143862B Ionic compound containing chiral amine-thiourea (urea) and its preparation method and application
06/23/2010CN101104617B Dihydropyrimidine compounds and use of the same in preparing medicament for curing and preventing virosis
06/22/2010US7741485 3-[4-Chloro-2-fluoro-5-{[isopropyl(methyl)amino]carbonylaminosulfonyl}phenyl]-1-methyl-2,4-dioxo-6-trifluoromethyl-1,2,3,4-tetrahydropyrimidine; crop protection agent
06/22/2010US7741342 Water-soluble thalidomine derivatives
06/22/2010US7741341 Benzimidazole-derivatives as factor Xa inhibitors
06/22/2010US7741339 Fab I inhibitors
06/22/2010US7741336 N-(1-Methyl-1-phenyl-ethyl)-3-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino]-methyl}-benzenesulfonamide, useful in the treatment of breast cancer
06/22/2010US7741329 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia
06/22/2010US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds
06/22/2010US7741327 Pyrrolidinone glucokinase activators
06/22/2010US7741316 Pharmacological uses of azetidine derivatives
06/22/2010US7741289 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
06/22/2010US7741102 Surface enhanced (resonance) Raman scattering with 2,4,6-trinitrostyryl-1H-benzotriazole; for detection of explosives and drugs; drug screening
06/22/2010CA2579915C Indole derivatives and their use as inhibitors of p53-mdm2 interaction
06/22/2010CA2523253C Methyl indoles and methyl pyrrolopyridines as alpha-1 adrenergic agonists
06/22/2010CA2462149C Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth
06/22/2010CA2444198C Nociceptin analogs
06/22/2010CA2412718C Viral polymerase inhibitors
06/17/2010WO2010068863A2 Pyrimidine compounds and methods of making and using same
06/17/2010WO2010068806A1 Amide derivatives as btk inhibitors in the treatment of allergic, autoimmune and inflammatory disorders as well as cancer
06/17/2010WO2010068761A2 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication
06/17/2010WO2010068760A2 New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
06/17/2010WO2010068663A1 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
06/17/2010WO2010068453A1 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
06/17/2010WO2010068311A1 5-lipoxygenase-activating protein inhibitor
06/17/2010WO2010068049A2 Process for preparing (r)-(+)-lansoprazole and intermediate used therein
06/17/2010WO2010067130A1 P38 map kinase inhibitors
06/17/2010WO2010066697A1 Fungicide hydroximoyl-heterocycles derivatives
06/17/2010WO2010066684A2 Pyridyloxyindoles Inhibitors of VEGF-R2 and Use Thereof for Treatment of Disease
06/17/2010WO2010066324A1 Quinazolinamide derivatives
06/17/2010WO2010027181A3 Anthracene derivative and organic electroluminescence element using the same
06/17/2010WO2010025451A3 5,8-difluoro-4-(2-(4-(heteroaryloxy)-phenyl)ethylamino)quinazolines and their use as agrochemicals
06/17/2010WO2010025436A3 Nitrogen and sulfur-containing heterocycle derivatives
06/17/2010US20100152447 Novel Method for Producing 4,4-(1-Methyl-1,2-Ethanediyl)-BIS-(2,6-Piperazinedione)
06/17/2010US20100152442 4-anilino quinazoline derivatives as antiproliferative agents
06/17/2010US20100152260 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
06/17/2010US20100152259 Angiotensin ii receptor antagonists
06/17/2010US20100152258 Angiotensin ii receptor antagonists
06/17/2010US20100152219 Pyrazole derivatives as inhibitors of receptor tyrosine kinases
06/17/2010US20100152216 Monocyclic anilide spirolactam cgrp receptor antagonists
06/17/2010US20100152211 Inhibitors of human phosphatidylinositol 3-kinase delta
06/17/2010US20100152207 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
06/17/2010US20100152197 (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives
06/17/2010US20100152195 Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors
06/17/2010US20100152193 Pyridazinones
06/17/2010US20100152190 Substituted Pyrrolidine-2-Carboxamides
06/17/2010US20100152188 Novel Heterocyclic Compounds
06/17/2010US20100152184 Pharmaceutical compounds
06/17/2010US20100152182 2,4- Di(hetero)-arylamino-pyrimidine Derivatives as ZAP-70 and/or SYK inhibitors
06/17/2010US20100152167 Pyrimidine derivatives
06/17/2010US20100152166 Compounds and methods for modulating fxr
06/17/2010US20100152158 Substituted Disulfonamide Compounds
06/17/2010US20100152155 Histone Deacetylase Inhibitors
06/17/2010US20100152138 Cyclic amine bace-1 inhibitors having a benzamide substituent
06/17/2010US20100152047 Piperazine Compounds Whith a Herbicidal Action
06/17/2010US20100150831 Modulators of cxcr7
06/17/2010US20100148161 Compound for organic electroluminescent device and organic electroluminescent device
06/17/2010CA2746354A1 P38 map kinase inhibitors
06/17/2010CA2746265A1 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication
06/17/2010CA2746264A1 New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
06/17/2010CA2745988A1 Quinazolinamide derivatives
06/17/2010CA2745969A1 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
06/17/2010CA2745922A1 Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
06/16/2010EP2196459A1 5-membered heterocyclic compound
06/16/2010EP2195302A2 Insecticidal substituted azinyl derivatives
06/16/2010EP2195288A2 Small molecule bradykinin b1 receptor antagonists
06/16/2010EP2194787A1 Vegfr inhibitors containing a zinc binding moiety
06/16/2010EP2035379B1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
06/16/2010EP2029580B1 Novel indol-pyrrol derivatives for the treatment of proliferative and inflammatory diseases
06/16/2010EP1492526B1 Conjugated prodrugs of cc-1065 analogs
06/16/2010CN1889949B PDK-1/Akt signaling inhibitors
06/16/2010CN1771032B Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors
06/16/2010CN1764650B 2, 3, 6-trisubstituted-4-pyrimidone derivatives
06/16/2010CN101743241A pyridazinone derivates
06/16/2010CN101743229A quinazolinamide derivatives
1 ... 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 ... 626